Salmeterol/Fluticasone Propionate
SCO113162
Approved small_molecule active
Quick answer
Salmeterol/Fluticasone Propionate for Chronic Obstructive Pulmonary Disease (COPD) is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Chronic Obstructive Pulmonary Disease (COPD)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active